Akso Health Group ADR Cash Flow Conversion Efficiency

Latest as of June 2025: 0.015x

Akso Health Group ADR cash flow conversion efficiency. Based on the latest financial reports, Akso Health Group ADR (AHG) has a cash flow conversion efficiency ratio of 0.015x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.01 Million) by net assets ($199.15 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Akso Health Group ADR (2015–2025)

Cash flow conversion efficiency of Akso Health Group ADR from 2015 to 2025. This chart illustrates how Akso Health Group ADR's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Akso Health Group ADR stock price today for real-time trading data and today's change.

Akso Health Group ADR Cash Flow Conversion Ratio Explained

Akso Health Group ADR cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Akso Health Group ADR Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Akso Health Group ADR ranked by their cash flow conversion efficiency. Also see Akso Health Group ADR stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Suzhou Hycan Holdings Co Ltd
SHE:002787
0.089x
Aerospace Cf
SHG:600855
-0.017x
Suning Universal Co Ltd
SHE:000718
0.008x
Ningbo Peace Bird Fashion
SHG:603877
0.044x
Caisse Régionale de Crédit Agricole Mutuel de Paris et d-Ile-de-France
PA:CAF
0.025x
Chongqing Pharscin Pharmaceutical Co Ltd
SHE:002907
0.000x
INKON Life Technology Co Ltd
SHE:300143
0.027x
Beijing eGOVA
SHE:300075
-0.007x

Annual Cash Flow Conversion Efficiency for Akso Health Group ADR (2015–2025)

The table below shows the annual cash flow conversion efficiency of Akso Health Group ADR from 2015 to 2025. Review cash generation quality of Akso Health Group ADR to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 $199.15 Million $1.18 Million 0.006x -39.45%
2024-03-31 $138.42 Million $1.35 Million 0.010x +102.65%
2023-03-31 $8.84 Million $-3.25 Million -0.368x +47.60%
2022-03-31 $12.29 Million $-8.63 Million -0.702x -220.60%
2021-03-31 $17.27 Million $10.06 Million 0.582x +150.14%
2020-03-31 $48.10 Million $-55.87 Million -1.161x -8387.46%
2019-03-31 $126.50 Million $-1.73 Million -0.014x -102.18%
2018-03-31 $140.04 Million $87.72 Million 0.626x +79.78%
2017-03-31 $23.50 Million $8.19 Million 0.348x -30.51%
2016-03-31 $14.01 Million $7.03 Million 0.501x -35.05%
2015-03-31 $3.35 Million $2.59 Million 0.772x --

About Akso Health Group ADR

NASDAQ:AHG USA Medical Distribution
Market Cap
$1.16 Billion
Market Cap Rank
#9467 Global
#2658 in USA
Share Price
$2.12
Change (1 day)
+7.07%
52-Week Range
$1.12 - $2.50
All Time High
$40.16
About

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The compan… Read more